Are there any indications for giving an amiodarone (amio) bolus without a drip?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amiodarone Bolus Without Drip: Clinical Indications

Yes, there are specific indications for giving an amiodarone bolus without a maintenance drip, primarily in the cardiac arrest setting for shock-refractory ventricular fibrillation/pulseless ventricular tachycardia (VF/pVT).

Primary Indication: Cardiac Arrest with VF/pVT

The American Heart Association guidelines explicitly support bolus-only dosing of amiodarone during cardiac arrest resuscitation for shock-refractory VF/pVT. 1

Dosing Protocol for Cardiac Arrest

  • First bolus: 300 mg IV/IO administered rapidly 1
  • Second bolus (if needed): 150 mg IV/IO 1
  • No maintenance infusion is specified or required in the cardiac arrest algorithms 1

Key Clinical Context

  • Amiodarone boluses are given after CPR, defibrillation attempts, and vasopressor (epinephrine) administration have failed to terminate VF/pVT 1
  • The goal is immediate rhythm conversion during active resuscitation, not long-term rhythm maintenance 1
  • These boluses improve short-term outcomes like return of spontaneous circulation (ROSC) and survival to hospital admission, though no antiarrhythmic has proven long-term survival benefit 1

When Maintenance Infusion IS Required

Life-Threatening Arrhythmias with Perfusing Rhythm

  • For hemodynamically stable ventricular tachycardia or recurrent arrhythmias requiring ongoing suppression, the standard protocol includes both loading and maintenance infusion 1
  • Loading: 150 mg IV bolus over 10 minutes, then 1 mg/min for 6 hours, then 0.5 mg/min for 18 hours 1

Post-ROSC Considerations

  • After successful resuscitation, prophylactic antiarrhythmic infusion may be considered to prevent recurrent arrest, particularly during transport 1
  • However, this represents a different clinical scenario than the initial cardiac arrest bolus dosing 1

Critical Safety Considerations

Hypotension Risk

  • IV amiodarone causes hypotension in approximately 16% of patients due to vasoactive solvents and vasodilation 2
  • Bolus administration during cardiac arrest carries lower hypotension risk because patients are already pulseless and receiving vasopressors 1
  • In perfusing patients, slower infusion rates (over 10 minutes minimum for 150 mg dose) are essential to minimize hypotension 2

Contraindications for Bolus-Only Approach

  • Do NOT use amiodarone bolus for pulseless electrical activity (PEA) or asystole - it is only indicated for VF/pVT 3
  • Amiodarone is contraindicated in patients with bradycardia or heart block without a pacemaker 2

Practical Algorithm

During Active Cardiac Arrest (Pulseless Patient)

  1. Confirm rhythm is VF or pulseless VT 3
  2. Ensure CPR quality, defibrillation attempts, and epinephrine have been given 3
  3. Administer 300 mg amiodarone IV/IO bolus (can be given undiluted for speed) 4
  4. Continue CPR and defibrillation attempts 1
  5. If VF/pVT persists, give second 150 mg bolus 1
  6. No maintenance drip needed during pulseless arrest 1

After ROSC (Return of Pulse)

  1. Reassess need for ongoing antiarrhythmic therapy 1
  2. Consider maintenance infusion if recurrent arrhythmias are anticipated 1
  3. Transition to oral dosing when clinically appropriate 1

Common Pitfalls to Avoid

  • Never combine amiodarone with lidocaine - use one or the other, never both, due to increased toxicity risk without proven benefit 5
  • Do not delay CPR or defibrillation to prepare amiodarone infusion - bolus dosing allows rapid administration 4
  • Undiluted amiodarone can be safely used in cardiac arrest settings when time is critical, without causing unmanageable hemodynamic effects 4
  • Remember that amiodarone boluses during cardiac arrest represent a Class IIb recommendation (may be considered), not Class I (should be done) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amiodarone-Induced Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Pulseless Electrical Activity Arrest

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antiarrhythmic Medication Use in Cardiac Arrest

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.